Avidity Partners Management LP Merck & Co., Inc. Transaction History

Avidity Partners Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $21.9 Million - $23.5 Million	-177,000 Reduced 35.26%	325,000 $40.2 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $56.8 Million - $66.2 Million	502,000 New	502,000 $66.2 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $61.8 Million - $68.9 Million	600,000 New	600,000 $63.8 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $198 Million - $224 Million	-2,370,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $174 Million - $195 Million	2,370,000 New	2,370,000 $194 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $82.1 Million - $91.1 Million	-1,144,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $83.7 Million - $94.9 Million	1,144,300 New	1,144,300 $94.9 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $34.6 Million - $39.4 Million	-492,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$63.36 - $87.82 $31.2 Million - $43.2 Million	492,000 New	492,000 $37.9 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.